Background: There is considerable variation in BCG scar failure rate on available data and
correlation between BCG scar and tuberculin conversion remains controversial. Through …

Objective To test the hypothesis that having a scar and a positive tuberculin skin test (TST)
response after vaccination with B acille C almette–G uérin (BCG) is associated with reduced …

Objectives. To determine the sensitivity of the bacillus Calmette-Guérin (BCG) scar as an
indicator of previous vaccination and to ascertain the tuberculin skin test (TST) response in …

Bacille Calmette-Guérin (BCG) vaccination generally leads to scar formation and tuberculin
skin test (TST) reactivity. This study aimed at analysing these 2 parameters and their …

A total of 387 healthy full term infants who received BCG vaccination at birth were evaluated
by the tuberculin PPD test at 6–8 weeks post vaccination. A total of 92% of these infants had …

A study published in December issue of the Journal (l) found no difference in the immune
response in newborns who received BCG as compared to older infants and recommended …

Background: Recent studies have suggested that bacille Calmette-Guérin (BCG)
immunization may have a nonspecific beneficial effect on infant survival and that the effect …

BACKGROUND: Tuberculosis remains a major cause of morbidity and mortality worldwide.
Bacille Calmette Guerin (BCG) is the current vaccine for tuberculosis. The absence or …

Objective: To find out the incidence of BCG-scar failure, in BCG vaccinated children and
assess their in vitro cellular response. Design: Four year prospective cohort observational …

Objective: To evaluate the efficacy of bacillus Calmette Guérin (BCG) vaccine in pre-term
infants. Design: BCG vaccine was given to three groups of neonates: 1) 36 pre-terms born at …